Healthy Heart Screen
We see the effect of arterial disease on our community when we read the obituaries. Or a friend or family member suffers a heart attack or stroke or becomes diabetic or demented. Or it happens to us.
Our goal is to PREVENT AND REVERSE arterial and metabolic disease. That means finding it early and fixing it. Don't just wait to intervene once something has gone wrong. Rescue can save your life, but when seconds count, the ambulance will be here in minutes.
The Center for Prevention developed our Healthy Heart Screen process to detect and demonstrate arterial and metabolic disease to motivate early intervention and disease reversal with a process that is noninvasive, quick and inexpensive.
Some elements are similar to the Lifeline Screening program, but we designed it to be a better value and more meaningful for early disease detection and reversal. But if you've had a Lifeline Screening, we will review your results with you in a complimentary 15 minute meeting.
Carotid Ultrasound Screen
Ultrasound allows us to look for atherosclerotic plaque in the arteries. If plaque is seen, we recommend further detailed assessment using Carotid Intima Media Thickness ultrasound scans to fully assess the disease and measure the effectiveness of treatment.
Body Composition Analysis
The Inbody 570 uses Direct Segmental Multi-frequency Bioelectrical Impedance Analysis to report what you are made of. This information gives insight into Insulin Resistance/ Prediabetes/ Type 2 Diabetes as well as signs of other potential health risks. The meaurements allow us to motivate and maintain motivation to get off the carbs and off the couch.
Atrial Fibrillation Test
A single lead EKG detects atrial fibrillation and other irregularities of your heart beat. Atrial Fibrillation is an irregular heartbeat that can lead to blood clots, stroke and heart attack. People living with AFIB are 2x more likely to suffer a heart attack and 5x more likely to have a stroke.
Records current treatment, past events, family history and lifestyle issues that contribute to arterial and metabolic disease. Guides recommendations to tailor further assessment recommendations to match risk and costs.